*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| C111 - Malignant neoplasm of posterior wall of nasopharynx - as a primary diagnosis code | C111 - Malignant neoplasm of posterior wall of nasopharynx - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 6.61 | |
| Readmission Rate (%) | 25.92 | |
| Unplanned Readmission Rate (%) | 13.76 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 129: MAJOR HEAD AND NECK PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) OR MAJOR DEVICE | DRG 147: EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 146: EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 133: OTHER EAR, NOSE, MOUTH AND THROAT O.R. PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 011: TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 6,332 | ||||
| Total Hospitalizations with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | 26 | ||||
| DRG Share of Total Hospitalizations | 0.02 | ||||
| % of Total ICD C111 - Malignant neoplasm of posterior wall of nasopharynx in DRG | 22.03 | ||||
| Avg LOS at DRG | 5.14 | ||||
| Avg LOS with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | 4.46 | ||||
| Readmission Rate at DRG | 14.35 | ||||
| Readmission Rate with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | NA | ||||
| Unplanned Readmission Rate at DRG | 7.64 | ||||
| Unplanned Readmission Rate with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | NA | ||||
| Total Medicare payments at DRG | $113,818,459 | ||||
| Total Medicare payments with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | $437,131 | ||||
| Total Medicare payment per Day at DRG | $3,496 | ||||
| Total Medicare payment per Day with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | $3,768 | ||||
| Total Medicare payment per Hospitalization at DRG | $17,975 | ||||
| Total Medicare payment per Hospitalization with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | $16,813 | ||||
| Total Medicare Charges at DRG | $599,317,955 | ||||
| Total Medicare Charges with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | $2,035,498 | ||||
| Avg Charges at DRG | $94,649 | ||||
| Avg Charges with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | $78,288 | ||||
| Mortality Rate at DRG | 0.74 | ||||
| Mortality Rate with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | NA | ||||
| SNF Discharge Rate at DRG | 9.41 | ||||
| SNF Discharge Rate with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | NA | ||||
| Home Discharge Rate at DRG | 64.53 | ||||
| Home Discharge Rate with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | 80.77 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 129: MAJOR HEAD AND NECK PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) OR MAJOR DEVICE | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 147: EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 012: TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 146: EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 6,332 | ||||
| Total Hospitalizations with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | 34 | ||||
| DRG Share of Total Hospitalizations | 0.02 | ||||
| % of Total ICD C111 - Malignant neoplasm of posterior wall of nasopharynx in DRG | 6.85 | ||||
| Avg LOS at DRG | 5.14 | ||||
| Avg LOS with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | 4.32 | ||||
| Readmission Rate at DRG | 14.35 | ||||
| Readmission Rate with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | NA | ||||
| Unplanned Readmission Rate at DRG | 7.64 | ||||
| Unplanned Readmission Rate with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | NA | ||||
| Total Medicare payments at DRG | $113,818,459 | ||||
| Total Medicare payments with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | $558,111 | ||||
| Total Medicare payment per Day at DRG | $3,496 | ||||
| Total Medicare payment per Day with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | $3,797 | ||||
| Total Medicare payment per Hospitalization at DRG | $17,975 | ||||
| Total Medicare payment per Hospitalization with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | $16,415 | ||||
| Total Medicare Charges at DRG | $599,317,955 | ||||
| Total Medicare Charges with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | $2,849,131 | ||||
| Avg Charges at DRG | $94,649 | ||||
| Avg Charges with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | $83,798 | ||||
| Mortality Rate at DRG | 0.74 | ||||
| Mortality Rate with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | NA | ||||
| SNF Discharge Rate at DRG | 9.41 | ||||
| SNF Discharge Rate with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | NA | ||||
| Home Discharge Rate at DRG | 64.53 | ||||
| Home Discharge Rate with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | 82.35 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 133: OTHER EAR, NOSE, MOUTH AND THROAT O.R. PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 130: MAJOR HEAD AND NECK PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 011: TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | |
|---|---|---|---|---|
| Total Hospitalizations at DRG | 6,433 | |||
| Total Hospitalizations with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | 16 | |||
| DRG Share of Total Hospitalizations | 0.02 | |||
| % of Total ICD C111 - Malignant neoplasm of posterior wall of nasopharynx in DRG | 3.23 | |||
| Avg LOS at DRG | 5.43 | |||
| Avg LOS with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | 8.0 | |||
| Readmission Rate at DRG | 19.1 | |||
| Readmission Rate with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | NA | |||
| Unplanned Readmission Rate at DRG | 11.74 | |||
| Unplanned Readmission Rate with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | NA | |||
| Total Medicare payments at DRG | $90,965,515 | |||
| Total Medicare payments with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | $222,771 | |||
| Total Medicare payment per Day at DRG | $2,605 | |||
| Total Medicare payment per Day with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | $1,740 | |||
| Total Medicare payment per Hospitalization at DRG | $14,140 | |||
| Total Medicare payment per Hospitalization with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | $13,923 | |||
| Total Medicare Charges at DRG | $478,604,560 | |||
| Total Medicare Charges with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | $1,288,236 | |||
| Avg Charges at DRG | $74,398 | |||
| Avg Charges with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | $80,515 | |||
| Mortality Rate at DRG | 1.26 | |||
| Mortality Rate with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | NA | |||
| SNF Discharge Rate at DRG | 11.66 | |||
| SNF Discharge Rate with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | NA | |||
| Home Discharge Rate at DRG | 62.18 | |||
| Home Discharge Rate with ICD C111 - Malignant neoplasm of posterior wall of nasopharynx | NA |
| No | ICD Diagnosis Code | Description |
|---|---|---|
| 1 | C770 | Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck |
| 2 | R1310 | Dysphagia, unspecified |
| 3 | Z87891 | Personal history of nicotine dependence |